 | Your browser does not display parts of our website correctly. We use the latest technology available to provide you with a high quality experience; please upgrade your browser to its latest version to view the contents properly: |
Stockwinners Market Radar for January 29, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
| INTC... | Hot Stocks20:04 EST Fly Intel: Top five weekend stock stories - Catch up on the weekend's top five stories with this list compiled by The Fly: 1. Bed Bath & Beyond (BBBY) is closing an additional 87 of its flagship stores and its entire Harmon chain of drugstores, as the retailer struggles to find financial support to keep its operations funded, The Wall Street Journal's Soma Biswas, Alexander Gladstone, Kate King, and Jodi Xu Klein report. The latest closings are in addition to a plan announced in August to shut 150 lower-performing Bed Bath & Beyond locations, a spokeswoman said. The company said Friday it is also closing five of its Buybuy Baby stores. The company had about 50 Harmon stores as of February 2022, the authors note. 2. China's top nuclear-weapons research institute has bought sophisticated U.S. computer chips at least a dozen times in the past two and half years, circumventing decades-old American export restrictions meant to curb such sales, The Wall Street Journal's Liza Lin and Dan Strumpf report. A Wall Street Journal review of procurement documents found that the state-run China Academy of Engineering Physics has managed to obtain the semiconductors made by U.S. companies such as Intel (INTC) and Nvidia (NVDA) since 2020 despite its placement on a U.S. export blacklist in 1997. The chips, which are widely used in data centers and personal computers, were acquired from resellers in China, the authors note. 3. Lowe's (LOW) shares are down 21% from their record highs hit in December 2021 but the stock isn't as reliant on the housing market as it might seem, Jacob Sonenshine writes in this week's edition of Barron's. These days, the business is being driven by company-specific factors, such as its continued growth in the higher-margin and more-stable contractor business, where it's narrowing the gap with Home Depot (HD), the author notes. The stock, meanwhile, trades at a discount to both its larger rival and the S&P 500 index, offering a compelling entry point for investors willing to bet Lowe's turnaround can continue, the publication adds. 4. Disney's (DIS) "Avatar: The Way of Water" won this weekend at the North American box office with an estimated $15.7M from 3,600 locations for a domestic total of $621M. James Cameron sequel is now the fourth top grossing film of all time at the global box office. Overseas, "The Way of Water" earned another $42.4M for a foreign cume of $1.496B. 5. Workday (WDAY) saw a positive mention in this week's edition of Barron's.
|
| PM | Hot Stocks19:51 EST Philip Morris announces agreement to extend, deepen collaboration with KT&G - Philip Morris announces a long-term collaboration with KT&G, South Korea's leading tobacco and nicotine manufacturer, to continue to commercialize KT&G's innovative smoke-free devices and consumables on an exclusive, worldwide basis. It builds on three years of successful collaboration that has seen PMI commercialize KT&G's products in more than 30 markets. The agreement covers fifteen years, to January 29, 2038, with performance-review cycles and associated commitments, based on volume, to be confirmed for each three-year period, to allow flexibility for evolving market conditions. PMI and KT&G expect these commitments to increase over the full duration of the agreement, starting with a total commitment for the first three-year period equivalent to 16 billion consumables. The agreement gives PMI continued exclusive access to KT&G's smoke-free brands and product-innovation pipeline, including offerings for low- and middle-income markets, that will enhance PMI's existing portfolio of smoke-free products. It gives KT&G continued access to PMI's global commercial infrastructure and experience commercializing smoke-free products to support the further expansion of KT&G's smoke-free business outside South Korea. Products sold under the agreement will be subject to assessment to ensure they meet the regulatory requirements in the markets where they are launched, as well as PMI's high standards of quality and scientific substantiation. PMI and KT&G will seek any necessary regulatory approvals that may be required on a market-by-market basis.
|
| BIIB ESALY | Hot Stocks19:12 EST Eisai, Biogen say lecanemab received Priority Review status in Japan - Eisai (ESALY) and Biogen (BIIB) announced that an application for manufacturing and marketing approval for lecanemab, an anti-amyloid-beta protofibril antibody, in Japan has been designated for Priority Review by the Japanese Ministry of Health, Labour and Welfare. Priority Review in Japan is granted to new medicines recognized as having high medical utility for serious diseases, and once designated for Priority Review, the target total review period is shortened. In Japan, Eisai submitted the manufacturing and marketing approval for lecanemab to the Pharmaceuticals and Medical Devices Agency on January 16, 2023. This application is based on the results of the Phase III Clarity AD study and the Phase IIb clinical study, which demonstrated that lecanemab treatment showed a reduction of clinical decline in early AD.
|
